Product Information
QUETIAPINE ER 150 MG TABLET is a generic product labeled by ACI Healthcare USA, Inc., priced at $0.1884 per EA under NDC 71093013602. Its NADAC has been published 419 times since May 16, 2018.
FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
ACI Healthcare USA, Inc.NDC
71093013602
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA209635FDA Approved
11/29/2017
TE Code
AB
On Market Since
11/29/2017
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 150 MG TABLET has been published 419 times since May 16, 2018, and over the history we have for it it has declined 73.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1884 per EA |
|---|---|
| All-time high | $0.7134 (May 16, 2018) |
| All-time low | $0.1497 (Nov 20, 2024) |
| 52-week high | $0.2205 |
| 52-week low | $0.1813 |
| Median price | $0.2591 |
| Average price | $0.3079 |
| Largest weekly change | +43.5% (Apr 21, 2021) |
| Weeks tracked | 419 |
| Tracking since | May 16, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
+3.9%
1Y
-1.6%
3Y
+9.1%
5Y
-29.9%
All
-73.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ACI Healthcare USA, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Quetiapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 150 MG TABLET, manufactured by ACI Healthcare USA, Inc., is $0.1884 per EA (NDC 71093013602), effective May 20, 2026.
How has the price of QUETIAPINE ER 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 150 MG TABLET has declined 73.6%. It has been tracked across 419 weekly CMS publications since May 16, 2018.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 150 MG TABLET?
Since May 16, 2018, the NADAC for QUETIAPINE ER 150 MG TABLET has ranged from a low of $0.1497 (Nov 20, 2024) to a high of $0.7134 (May 16, 2018), with a median of $0.2591 per EA.
Are there cheaper alternatives to QUETIAPINE ER 150 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE ER 150 MG TABLET, is $0.1836 per EA — about 3% below QUETIAPINE ER 150 MG TABLET.
Who manufactures QUETIAPINE ER 150 MG TABLET?
QUETIAPINE ER 150 MG TABLET (NDC 71093013602) is labeled by ACI Healthcare USA, Inc., and CMS classifies it as a generic product.